Atezolizumab Immunotherapy in Patients With Advanced NSCLC

Clinical trial NCT03102242 · COMPLETED

Trial details

NCT number: NCT03102242
Sponsor: Alliance Foundation Trials, LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2017-11-01
Primary completion: 2020-06-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.